Trials / Completed
CompletedNCT06148948
A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BI 1584862 in Japanese Healthy Male Subjects (Single- Masked, Randomised, Placebo-controlled, Parallel Group Design)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The goal of this trial is to investigate safety, tolerability and pharmacokinetics of BI 1584862 in healthy male subjects of Japanese ethnicity following oral administration of single rising doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1584862 | BI 1584862 |
| DRUG | Placebo | Placebo matching BI 1584862 |
Timeline
- Start date
- 2023-12-25
- Primary completion
- 2024-05-21
- Completion
- 2024-05-21
- First posted
- 2023-11-28
- Last updated
- 2024-11-13
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06148948. Inclusion in this directory is not an endorsement.